Australia markets close in 1 hour 33 minutes

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
50.37-1.07 (-2.08%)
At close: 04:00PM EDT
52.14 +1.77 (+3.51%)
After hours: 05:55PM EDT

Globus Medical, Inc.

2560 General Armistead Avenue
Audubon, PA 19403
United States
610 930 1800
https://www.globusmedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees5,000

Key executives

NameTitlePayExercisedYear born
Mr. David C. PaulCo-Founder & Executive Chairman1.09MN/A1967
Mr. Daniel T. ScavillaPresident, CEO & Director1.37MN/A1965
Mr. Keith W. PfeilCFO & COO675.89kN/A1980
Ms. Kelly G. Huller Esq.Senior VP, General Counsel & Secretary543.24k624.35k1972
Mr. Brian J. KearnsSenior Vice President of Business Development & Investor RelationsN/AN/A1967
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Corporate governance

Globus Medical, Inc.’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 10; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.